Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 15, Number 35, 2009

Articles

Rhodopsin and the Others: A Historical Perspective on Structural Studies of G Protein-Coupled Receptors
pp. 3994-4002(9)
Authors: Costanzi, Stefano; Siegel, Jeffrey; Tikhonova, Irina G.; Jacobson, Kenneth A.

Favourites:
ADD

Unraveling the Structure and Function of G Protein-Coupled Receptors Through NMR Spectroscopy
pp. 4003-4016(14)
Authors: Tikhonova, Irina G.; Costanzi, Stefano

Favourites:
ADD

Progress in Elucidating the Structural and Dynamic Character of G Protein-Coupled Receptor Oligomers for Use in Drug Discovery
pp. 4017-4025(9)
Authors: Bortolato, A.; Mobarec, J. C.; Provasi, D.; Filizola, M.

Favourites:
ADD

Customizing G Protein-Coupled Receptor Models for Structure-Based Virtual Screening
pp. 4026-4048(23)
Authors: de Graaf, Chris; Rognan, Didier

Favourites:
ADD

G Protein-Coupled Receptors: Target-Based In Silico Screening
pp. 4049-4068(20)
Authors: Senderowitz, Hanoch; Marantz, Yael

Favourites:
ADD

Human A3 Adenosine Receptor as Versatile G Protein-Coupled Receptor Example to Validate the Receptor Homology Modeling Technology
pp. 4069-4084(16)
Authors: Morizzo, Erika; Federico, Stephanie; Spalluto, Giampiero; Moro, Stefano

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content